First Bank & Trust Abb Vie Inc. Transaction History

First Bank & Trust

$510 Million
Q3 2024

A detailed history of First Bank & Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, First Bank & Trust holds 16,654 shares of ABBV stock, worth $2.92 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

16,654

Previous 16,828 1.03%

Holding current value

$2.92 Million

Previous $2.89 Million 13.93%

% of portfolio

0.64%

Previous 0.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $28,508 - $34,683	-174 Reduced 1.03%	16,654 $3.29 Million
Q2 2024 Jul 09, 2024	SELL	$154.79 - $180.76 $306,174 - $357,543	-1,978 Reduced 10.52%	16,828 $2.89 Million
Q1 2024 Apr 17, 2024	BUY	$159.82 - $182.1 $108,837 - $124,010	681 Added 3.76%	18,806 $3.42 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $9,356 - $10,537	68 Added 0.38%	18,125 $2.81 Million
Q3 2023 Oct 11, 2023	SELL	$133.59 - $154.65 $16,832 - $19,485	-126 Reduced 0.69%	18,057 $2.69 Million
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $7,420 - $9,234	-56 Reduced 0.31%	18,183 $2.45 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $20,823 - $23,981	-144 Reduced 0.78%	18,239 $2.91 Million
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $47,578 - $57,059	344 Added 1.91%	18,383 $2.97 Million
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $18,520 - $21,242	-138 Reduced 0.76%	18,039 $2.42 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $1.34 Million - $1.71 Million	-9,748 Reduced 34.91%	18,177 $2.78 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $290,487 - $360,413	-2,201 Reduced 7.31%	27,925 $4.53 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $22,560 - $28,545	210 Added 0.7%	30,126 $4.08 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $50,752 - $57,612	477 Added 1.62%	29,916 $3.23 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $3,261 - $3,633	31 Added 0.11%	29,439 $3.32 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $68,336 - $75,230	668 Added 2.32%	29,408 $3.18 Million
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $24,790 - $33,470	-308 Reduced 1.06%	28,740 $3.08 Million
Q3 2020 Oct 26, 2020	SELL	$85.91 - $100.83 $220,874 - $259,233	-2,571 Reduced 8.13%	29,048 $2.54 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $267,360 - $357,767	-3,644 Reduced 10.33%	31,619 $3.1 Million
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $86,301 - $130,843	1,338 Added 3.94%	35,263 $2.69 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $171,380 - $214,434	2,376 Added 7.53%	33,925 $3 Million
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $221,752 - $266,610	3,521 Added 12.56%	31,549 $2.39 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $139,743 - $178,625	2,127 Added 8.21%	28,028 $2.04 Million
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $207,352 - $244,043	2,688 Added 11.58%	25,901 $2.09 Million
Q4 2018 Jan 28, 2019	BUY	$77.85 - $96.01 $870,440 - $1.07 Million	11,181 Added 92.93%	23,213 $2.14 Million
Q3 2018 Oct 10, 2018	BUY	$88.91 - $98.84 $25,961 - $28,861	292 Added 2.49%	12,032 $1.16 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $513,182 - $607,210	-5,716 Reduced 32.75%	11,740 $1.09 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $464,558 - $622,087	-5,049 Reduced 22.44%	17,456 $1.65 Million
Q4 2017 Jan 18, 2018	SELL	$89.56 - $98.21 $1.34 Million - $1.46 Million	-14,913 Reduced 39.86%	22,505 $2.18 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $2.61 Million - $3.34 Million	37,418	37,418 $3.32 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account